We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Mark - A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma
Tomer M Mark, MD, MSc
Weill Cornell Medical College
New York, New York, USA
12.06.11

Be the first to comment

 related articles